The independent source for health policy research, polling, and news.
281 - 300 of 772 Results
Physicians and attorneys say it’s a question of when — not if — a pregnant person dies from lack of care in a state with an abortion ban, potentially setting the stage for a malpractice lawsuit that could pressure providers to reconsider delaying or denying care.
As more states restrict gender-affirming care for transgender people, some are relocating to more welcoming destinations, such as California, Illinois, Maryland, and Nevada, where they don't have to worry about being locked out of medical care.
More than a million Americans have lost Medicaid coverage since pandemic protections ended. The Biden administration is asking states to slow disenrollment, but that does not mean states must listen. Meanwhile, a Supreme Court decision gives Medicaid beneficiaries the right to sue over their care, and a new deal preserves coverage of preventive services nationwide as a Texas court case continues. Rachel Cohrs of Stat, Alice Miranda Ollstein of Politico, and Sandhya Raman of CQ Roll Call join KFF Health News’ Mary Agnes Carey to discuss these issues and more. Also this week, KFF Health News’ Julie Rovner interviews Dan Mendelson, CEO of Morgan Health, a new unit of JPMorgan Chase, about employers’ role in insurance coverage.
A push is underway to create a National Patient Safety Board modeled after the National Transportation Safety Board, an independent federal agency that investigates plane crashes and other transportation disasters. But unlike the NTSB, some patient safety advocates say, the current proposal is toothless and wouldn’t provide transparency about the nation’s hospitals.
California officials are stepping up efforts to combat the spread of xylazine, a powerful animal sedative that’s increasingly being used by people, often with devastating results. It’s mostly been an East Coast phenomenon, but ‘tranq,’ as it is known, is beginning to appear in the Golden State.
Montana, Alaska, Mississippi, Missouri, South Dakota, Texas, Utah, and Wyoming are among the latest states moving to provide health coverage for up to a year after pregnancy through the federal-state health insurance program for low-income people.
The well-known “Amanita muscaria” mushroom is legal to possess and consume in 49 states. The market for gummies, powders, and capsules containing extracts of the fungus is raising eyebrows, though, amid concerns from the FDA and in the absence of human clinical trials.
Family planning clinics are getting caught between state abortion bans and a federal requirement to refer patients for abortion care on request.
Doctors say they are reluctant to practice in abortion-banned states, where making the best decision for a patient could run afoul of the law. Even former President Donald Trump’s surgeon general is concerned about the repercussions for women’s health, writes KFF Health News’ chief Washington correspondent, Julie Rovner.
State lawmakers have recently been debating whether and how to stiffen punishments for dealers, while Gov. Gavin Newsom is targeting fentanyl trafficking and distributing more naloxone. The problem, experts say, is one with no easy or clear answers.
After local leaders in rural Nevada reached an impasse over a proposed Planned Parenthood clinic, an anti-abortion activist pitching local abortion bans across the U.S. arrived at their remote City Hall.
The Camp Lejeune Justice Act, which became law last year, created a pathway for veterans and their families to pursue damage claims against the government for toxic exposure at the military base. Now, advocates and lawmakers worry high lawyer fees could shortchange those injured.
Democratic politicians in California and Oregon are reconsidering the restrictions of involuntary commitment laws. They argue that not helping people who are seriously ill and living in squalor on the streets is inhumane.
Nearly 30 states have active or proposed laws authorizing independent hospital police forces. Groups representing nurses and hospitals say the laws address the daily realities of patients who become aggressive or agitated. But critics worry about unintended consequences.
KFF Health News and California Healthline staff made the rounds on national and local media this week to discuss their stories. Here’s a collection of their appearances.
The public health emergency declaration for covid-19 ends May 11, ushering in major changes in how Americans can access and pay for the vaccines, treatments, and tests particular to the culprit coronavirus. But not everyone will experience the same changes, creating a confusing patchwork of coverage — not unlike health coverage for other diseases. Meanwhile, outside advisers to the FDA formally recommended allowing a birth control pill to be sold without a prescription. If the FDA follows the recommendation, it would represent the first over-the-counter form of hormonal contraception. Margot Sanger-Katz of The New York Times, Tami Luhby of CNN, and Joanne Kenen of the Johns Hopkins Bloomberg School of Public Health and Politico join KFF Health News’ Julie Rovner to discuss these issues and more. Plus for “extra credit” the panelists suggest health policy stories they read this week they think you should read, too.
Drugmakers, pharmacies, and physicians blame pharmacy benefit managers for high drug prices. Congress is finally on board, too, but will it matter?
Individuals newly released from prison are 40 times as likely to die of opioid overdoses than members of the general population, researchers say. In response, California corrections officials aim to arm departing inmates with an antidote that can be used to reverse the effects of opioid poisoning.
Sparing veterans and defense spending, as Republicans promise, would be extremely difficult, requiring cuts of more than 20% in other parts of the budget. The Republicans’ Limit, Save, Grow Act already proposes a $2 billion cut to the Department of Veterans Affairs by taking back unspent covid relief funding.
As marijuana has become far more mainstream, potent, and sometimes dangerous, uneven regulation at the state and federal levels leaves consumers at risk.
© 2026 KFF